Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.86 EUR | -4.37% | +18.47% | +66.67% |
04-16 | Finland’s Nightingale Health Plots US Expansion | MT |
04-16 | Nightingale Health to Establish A Laboratory in the United States | CI |
Sales 2024 * | 4.7M 5.03M 6.87M | Sales 2025 * | 8.7M 9.31M 12.72M | Capitalization | 112M 120M 164M |
---|---|---|---|---|---|
Net income 2024 * | -16M -17.13M -23.4M | Net income 2025 * | -16M -17.13M -23.4M | EV / Sales 2024 * | 9.86 x |
Net cash position 2024 * | 65.9M 70.56M 96.36M | Net cash position 2025 * | 52.2M 55.89M 76.33M | EV / Sales 2025 * | 6.9 x |
P/E ratio 2024 * |
-6.89
x | P/E ratio 2025 * |
-6.89
x | Employees | 81 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.93% |
Latest transcript on Nightingale Health Oyj
1 day | -4.37% | ||
1 week | +18.47% | ||
Current month | +78.85% | ||
1 month | +78.85% | ||
3 months | +61.74% | ||
6 months | +82.35% | ||
Current year | +66.67% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Würtz
FOU | Founder | - | 01-12-31 |
Satu Saksman
FOU | Founder | 48 | 01-12-31 |
Pasi Soininen
FOU | Founder | - | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-12-16 | |
Chairman | 61 | 20-12-31 | |
Olli Pekka Karhi
BRD | Director/Board Member | 61 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.86 | -4.37% | 179,082 |
24-04-25 | 1.945 | +14.41% | 339,442 |
24-04-24 | 1.7 | +1.19% | 109,897 |
24-04-23 | 1.68 | -1.18% | 107,643 |
24-04-22 | 1.7 | +8.28% | 259,558 |
Delayed Quote Nasdaq Helsinki, April 26, 2024 at 11:29 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.67% | 120M | |
+4.36% | 32.47B | |
+15.51% | 7.45B | |
+22.93% | 3.89B | |
-16.29% | 3.17B | |
-25.96% | 1.28B | |
-36.14% | 1.09B | |
-35.42% | 902M | |
-0.13% | 893M | |
-24.12% | 857M |
- Stock Market
- Equities
- HEALTH Stock